Thousand Oaks-based biotech giant Amgen is teaming up with Array BioPharma out of Boulder, Colo. to research and develop new treatments for autoimmune disorders. Array has chemistry expertise and it discovered the target and lead inhibitors, according to a news release on July 18. For its part in the collaboration agreement, Amgen will work on…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
